Showing results (141-150 of 296) with videos related to
Sort By:
Pageof 30
Clinical Colorectal Cancer|April 8, 2016
Autologous Cytokine-Induced Killer Cells Improves Overall Survival of Metastatic Colorectal Cancer Patients: Results From a Phase II Clinical TrialHua Zhao, Yang Wang, Jinpu Yu, et al.Cancer Biotherapy & Radiopharmaceuticals|July 30, 2011
Synergistic effect of CH-296 and interferon gamma on cytokine-induced killer cells expansion for patients with advanced-stage malignant solid tumorsJinpu Yu, Xiubao Ren, Hui Li, et al.Annals of Translational Medicine|March 14, 2022
Vasohibin 2 promotes lymphangiogenesis of lung squamous cell carcinoma through snail-dependent vascular endothelial growth factor-D (VEGF-D) signaling pathwayPengpeng Liu, Rui Zhang, Lei Han, et al.Plos One|January 31, 2017
Mesenchymal Cell Reprogramming in Experimental MPLW515L Mouse Model of MyelofibrosisYing Han, Lanzhu Yue, Max Wei, et al.Experimental Hematology & Oncology|October 29, 2024
Advances in adoptive cellular immunotherapy and therapeutic breakthroughs in multiple myelomaJingjing Pu, Ting Liu, Amit Sharma, et al.Cancers|April 13, 2024
The Role of Natural Killer Cells in the Tumor Immune Microenvironment of EBV-Associated Nasopharyngeal CarcinomaShuzhan Li, Wei Dai, Ngar-Woon Kam, et al.Plos One|February 19, 2013
Dysfunctional activation of neurotensin/IL-8 pathway in hepatocellular carcinoma is associated with increased inflammatory response in microenvironment, more epithelial mesenchymal transition in cancer and worse prognosis in patientsJinpu Yu, Xiubao Ren, Yongzi Chen, et al.Molecular Oncology|June 8, 2022
PGAM1 regulation of ASS1 contributes to the progression of breast cancer through the cAMP/AMPK/CEBPB pathwayMin Liu, Runmei Li, Min Wang, et al.Thoracic Cancer|March 6, 2020
Factors related to rapid progression of non-small cell lung cancer in Chinese patients treated using single-agent immune checkpoint inhibitor treatmentLiang Zhang, Lianwei Bai, Xianhong Liu, et al.Biochemical Pharmacology|December 19, 2015
Knock-down of CIAPIN1 sensitizes K562 chronic myeloid leukemia cells to Imatinib by regulation of cell cycle and apoptosis-associated members via NF-κB and ERK5 signaling pathwayJian Wang, Qinghua Li, Chijuan Wang, et al.Pageof 30